| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.1 | 0.5 |